Literature DB >> 23851929

Effects of a three party healthcare network on the incidence levels of drug related problems.

Thomas Fiß1, Claudia Meinke-Franze, Neeltje van den Berg, Wolfgang Hoffmann.   

Abstract

BACKGROUND: Drug related problems (DRPs) are impairing patients' health and cause high costs. Neither delegation of home medication review nor regular pharmaceutical care are common in Germany.
OBJECTIVE: We aimed to reduce several DRP by the implementation of a three party healthcare team [AGnES-practice assistant, pharmacist, general practitioner (GP)] and adherence supporting strategies (using a medication reminder chart, medication compliance aid).
SETTING: The setting was ambulatory primary healthcare in German rural areas with a cohort of home-dwelling, elderly, mostly multimorbid patients with limited mobility (study period: 06/2006-12/2008).
METHODS: We conducted a prospective non-randomized implementation cohort study with home medication review (home medication review module; mean participation time: 9 months). Data collection was delegated to additionally qualified AGnES-practice assistants (AGnES: GP-supporting, community-based, e-health-assisted systemic intervention). The intervention comprised pharmaceutical care by the local pharmacy in addition to medical interventions by the GP. 408 patients (mean age: women: 80.7 years; men: 75.3 years) received both pharmaceutical care and at least one follow-up visit. MAIN OUTCOME MEASUREMENT: Outcome measurements comprised self-reported DRPs, objectively evaluated DRP, and prevalence of adherence supporting strategies.
RESULTS: The three party healthcare team approach reduced self-reported forgetfulness (7.7-3.2 %; p = 0.001), the proportion of patients with intermittent drug intake (5.3-1.3 %; p < 0.001), and the proportion of patients with potentially clinical relevant drug-drug interaction (61.6-51.2 %; p < 0.001). Self-reported adverse drug reactions decreased non-significantly (5.4-4.6 %; p = 0.564; all tests χ²-McNemar). The median number of active substances taken was reduced from 8 to 7 (p < 0.001; Wilcoxon signed rank test). The proportions of patients using medication charts and compliance aids increased significantly (75.2-90.3 %; p < 0.001) and (70.0-80.1 %; p > 0.001), respectively.
CONCLUSION: This is the first study evaluating effects of a three party team on DRPs in a primary healthcare setting in Germany. This approach led to reduction in the occurrence of several DRPs and improved adherence supporting strategies. However, the study is a pre-post analysis, and had no control group.

Entities:  

Mesh:

Year:  2013        PMID: 23851929     DOI: 10.1007/s11096-013-9804-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  29 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  [Systematic drug documentation].

Authors:  M Schaefer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2005-07       Impact factor: 1.513

Review 3.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

4.  Evaluation of frequently used drug interaction screening programs.

Authors:  Priska Vonbach; André Dubied; Stephan Krähenbühl; Jürg H Beer
Journal:  Pharm World Sci       Date:  2008-04-16

5.  Frequency of inappropriate drugs in primary care: analysis of a sample of immobile patients who received periodic home visits.

Authors:  Thomas Fiss; Adina Dreier; Claudia Meinke; Neeltje van den Berg; Christoph Alexander Ritter; Wolfgang Hoffmann
Journal:  Age Ageing       Date:  2010-09-07       Impact factor: 10.668

6.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

7.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

Review 8.  A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications.

Authors:  Johnson George; Rohan A Elliott; Derek C Stewart
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Implementing telemonitoring in the daily routine of a GP practice in a rural setting in northern Germany.

Authors:  Claudia Terschüren; Konstanze Fendrich; Neeltje van den Berg; Wolfgang Hoffmann
Journal:  J Telemed Telecare       Date:  2007       Impact factor: 6.184

10.  "I haven't even phoned my doctor yet." The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis.

Authors:  Charlotte Salter; Richard Holland; Ian Harvey; Karen Henwood
Journal:  BMJ       Date:  2007-04-20
View more
  6 in total

1.  Large scale implementation of clinical medication reviews in Dutch community pharmacies: drug-related problems and interventions.

Authors:  Thomas G H Kempen; Caroline H P A van de Steeg-van Gompel; Petra Hoogland; Yuqian Liu; Marcel L Bouvy
Journal:  Int J Clin Pharm       Date:  2014-04-16

Review 2.  Prevalence of drug interactions in elderly patients with multimorbidity in primary care.

Authors:  Susana Sánchez-Fidalgo; Maria Isabel Guzmán-Ramos; Mercedes Galván-Banqueri; Máximo Bernabeu-Wittel; Bernardo Santos-Ramos
Journal:  Int J Clin Pharm       Date:  2017-02-25

3.  Patient-perceived barriers and facilitators to the implementation of a medication review in primary care: a qualitative thematic analysis.

Authors:  Mirella Carolin Uhl; Christiane Muth; Ferdinand Michael Gerlach; Goentje-Gesine Schoch; Beate Sigrid Müller
Journal:  BMC Fam Pract       Date:  2018-01-05       Impact factor: 2.497

4.  Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.

Authors:  Joanna Ulley; Deborah Harrop; Ali Ali; Sarah Alton; Sally Fowler Davis
Journal:  BMC Geriatr       Date:  2019-01-18       Impact factor: 3.921

5.  Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial.

Authors:  Marianne Lea; Morten Mowé; Espen Molden; Kristin Kvernrød; Eva Skovlund; Liv Mathiesen
Journal:  BMJ Open       Date:  2020-12-29       Impact factor: 2.692

6.  An inventory of collaborative medication reviews for older adults - evolution of practices.

Authors:  A Kiiski; M Airaksinen; A Mäntylä; S Desselle; A Kumpusalo-Vauhkonen; T Järvensivu; M Pohjanoksa-Mäntylä
Journal:  BMC Geriatr       Date:  2019-11-21       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.